Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1876 AL 1890

Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers

Singh AV, Chandrasekar V, Janapareddy P, Mathews DE, Laux P, Luch A, Yang Y, Garcia-Canibano B, Balakrishnan S, Abinahed J, Al Ansari A, Dakua SP.

ACS Chem Neurosci. 2021 Jun 2;12(11):1835-1853. doi: 10.1021/acschemneuro.1c00087. Epub 2021 May 19.

Cortical Thickness from MRI to Predict Conversion from Mild Cognitive Impairment to Dementia in Parkinson Disease: A Machine Learning-based Model

Shin NY, Bang M, Yoo SW, Kim JS, Yun E, Yoon U, Han K, Ahn KJ, Lee SK.

Radiology. 2021 Aug;300(2):390-399. doi: 10.1148/radiol.2021203383. Epub 2021 May 25.

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar D, Sharma A, Flora SJS.

J Biochem Mol Toxicol. 2021 Aug;35(8):e22830. doi: 10.1002/jbt.22830. Epub 2021 May 28.

How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders

Carlson GA, Prusiner SB.

Int J Mol Sci. 2021 May 4;22(9):4861. doi: 10.3390/ijms22094861.

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis

Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L.

Int J Mol Sci. 2021 May 7;22(9):4958. doi: 10.3390/ijms22094958.

Biomarkers for neurodegenerative diseases

Hansson O.

Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.

Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier

Pathan N, Shende P.

J Control Release. 2021 Jul 10;335:398-407. doi: 10.1016/j.jconrel.2021.05.046. Epub 2021 Jun 2.

New strategies for fluorescently labeling proteins in the study of amyloids

Shimogawa M, Petersson EJ.

Curr Opin Chem Biol. 2021 Oct;64:57-66. doi: 10.1016/j.cbpa.2021.04.011. Epub 2021 Jun 3.

Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease

Yamamoto K.

Arch Pharm Res. 2021 Jun;44(6):564-573. doi: 10.1007/s12272-021-01334-6. Epub 2021 Jun 10.

From Kuru to Alzheimer: A personal outlook

Brunori M.

Protein Sci. 2021 Sep;30(9):1776-1792. doi: 10.1002/pro.4145. Epub 2021 Jun 26.

Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?

Matos MJ.

Future Med Chem. 2021 Aug;13(15):1301-1309. doi: 10.4155/fmc-2021-0119. Epub 2021 Jun 17.

Communicating chronic hydrocephalus: A review

Roblot P, Mollier O, Ollivier M, Gallice T, Planchon C, Gimbert E, Danet M, Renault S, Auzou N, Laurens B, Jecko V.

Rev Med Interne. 2021 Nov;42(11):781-788. doi: 10.1016/j.revmed.2021.05.018. Epub 2021 Jun 16.

Induction of specific brain oscillations may restore neural circuits and be used for the treatment of Alzheimer's disease

Chan D, Suk HJ, Jackson B, Milman NP, Stark D, Beach SD, Tsai LH.

J Intern Med. 2021 Nov;290(5):993-1009. doi: 10.1111/joim.13329. Epub 2021 Jun 22.

Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis

Pezzoli S, Sánchez-Valle R, Solanes A, Kempton MJ, Bandmann O, Shin JI, Cagnin A, Goldman JG, Merkitch D, Firbank MJ, Taylor JP, Pagonabarraga J, Kulisevsky J, Blanc F, Verdolini N, Venneri A, Radua J.

Neurosci Biobehav Rev. 2021 Sep;128:367-382. doi: 10.1016/j.neubiorev.2021.06.030. Epub 2021 Jun 22.

Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines

Milane L, Dolare S, Jahan T, Amiji M.

Nanomedicine. 2021 Oct;37:102422. doi: 10.1016/j.nano.2021.102422. Epub 2021 Jun 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias